Analytical Performance of the Exacto Test HIV Self-Test: A Cross-Sectional Field Study in the Democratic Republic of the Congo

3Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

The Democratic Republic of the Congo (DRC) has begun implementing HIV self-testing to boost the first "95" of the UNAIDS 95-95-95 targets by 2025. This study aims to assess the performance and usability of the Exacto Test HIV (Biosynex, Strasbourg, France) self-test in the lab and in the field. The Exacto Test HIV self-test demonstrated high virological performance (sensitivity, 99.6%; specificity, 100%) in the lab and in the field in the hand of untrained users (sensitivity, 100%; specificity, 98.9%). Taken together, the excellent performance and usability characteristics of the Exacto Test HIV (Biosynex) selftest make the kit a viable option for HIV self-testing in the DRC.

Cite

CITATION STYLE

APA

Tonen-Wolyec, S., Masidi, J. M., Lukusa, L. F. K., Dikumbwa, G. N., Sarassoro, A., & Bélec, L. (2020). Analytical Performance of the Exacto Test HIV Self-Test: A Cross-Sectional Field Study in the Democratic Republic of the Congo. Open Forum Infectious Diseases, 7(12). https://doi.org/10.1093/ofid/ofaa554

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free